Caas Capital Management »

Aspire Biopharma Hldgs Inc Wt Exp 021430 shares owned by Caas Capital Management

Quarter-by-quarter ownership of Aspire Biopharma Hldgs Inc Wt Exp 021430 (ASBPW) shares owned by Caas Capital Management from 13F filings

Historical chart of Caas Capital Management investment in Aspire Biopharma Hldgs Inc Wt Exp 021430

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs Inc Wt Exp 021430 held by Caas Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs Inc Wt Exp 021430 by Caas Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $5.1k 75k 0.07

More positions owned by Caas Capital Management

Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Citigroup Com New (C)
Goldman Sachs (GS)
JPMorgan Chase & Co. (JPM)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Wells Fargo & Company (WFC)
Bank of America Corporation (BAC)
Morgan Stanley Com New (MS)
Asml Holding N V N Y Registry Shs (ASML)
International Business Machines (IBM)
Visa Com Cl A (V)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Caas Capital Management

Top funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430

Adage Capital Partners GP
Saba Capital Management
Linden Advisors
Aristeia Capital
Highbridge Capital Management
Toronto-Dominion Bank
OZ Management
Verition Fund Management
Barclays
Clear Street
Millennium Management
Alberta Investment Management Corporation
Antara Capital
D. E. Shaw & Co
Wolverine Asset Management

View all funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430